piperidines has been researched along with Cadaver* in 8 studies
8 other study(ies) available for piperidines and Cadaver
Article | Year |
---|---|
Different lethal treatments induce changes in piperidine (1,1'-(1,2-ethanediyl)bis-) in the epidermal compounds of red imported fire ants and affect corpse-removal behavior.
Corpse-removal behavior of the red imported fire ant (RIFA) and the effects of lethal substances on RIFA signal communication were investigated in this study. The RIFA corpses, obtained through freezing, ether, 0.25 mg/L thiamethoxam, and starvation to death treatments, and naturally dead red fire ants were subjected to gas chromatography-mass spectrometry to identify the cuticular hydrocarbon profiles that had an effect on the corpse-removal behavior. The results showed that lethal toxic substances altered the epidermal compounds of RIFA and affected their corpse-removal behavior. Lethal toxic substances increased the number of worker touches with corpses and identification time of corpses. In addition, the content of piperidine (1,1'-(1,2-ethanediyl)bis-) on the surface of the corpse was different following the various treatments. Contamination with toxic substances resulted in the increased secretion of piperidine and led to increased identification time of corpses, number of touch with corpses, and total time for removal of corpses. Piperidine content was higher under conditions of natural death (4.67 ± 0.55%) and with thiamethoxam (10.43 ± 0.78%), freezing (0.83 ± 0.25%), and ether treatment (12.50 ± 0.70%) than under starvation treatment (0). The higher content of piperidine led to a longer number of touches with corpses and identification time. Piperidine compounds may be an element in warning information, which could affect the occurrence of different corpse-removal behaviors. Topics: Animals; Ants; Behavior, Animal; Cadaver; Epidermis; Freezing; Gas Chromatography-Mass Spectrometry; Insecticides; Piperidines; Social Behavior; Starvation; Thiamethoxam | 2020 |
Proposome for transdermal delivery of tofacitinib.
Tofacitinib citrate (TC) has recently gained interest in treating skin disorders such as psoriasis, atopic dermatitis and baldness. Unfortunately, the oral administration shows side effects, such as decreased neutrophil counts. To this end, the topical delivery of TC can be used to reduce the risk associated with systemic exposure. However, TC shows minimal absorption via skin. Hence, the objective of this study is to enhance the skin delivery of TC using a non-invasive approach. The liposomes based on propylene glycol, named as proposomes, carrying TC, were studied. The vesicle characteristics and in vitro skin permeation were assessed. The proposomes enhanced the skin permeability of TC by 4-11 folds. The composition of proposomes was found to affect the skin permeation and deposition of TC. The proposomes were stable for at least 6 months. Overall, proposomes were effective for targeted topical drug delivery. Topics: Administration, Cutaneous; Cadaver; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Humans; Liposomes; Male; Middle Aged; Particle Size; Piperidines; Propylene Glycol; Protein Kinase Inhibitors; Pyrimidines; Skin Absorption | 2020 |
Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
The effect of fatty acids on the skin permeation of donepezil base (DPB) and its hydrochloride salt (DPH) were studied in vitro using hairless mouse and human cadaver skin. DPB and DPH were solubilized in propylene glycol (PG) containing 1% (w/v) fatty acid, after which the in vitro permeation through hairless mouse skin and human cadaver skin were evaluated using Keshary-Chien diffusion cells. The optimized formulation obtained from the in vitro study was then tested in rats for an in vivo pharmacokinetic study. The relative in vitro skin permeation rate of donepezil (DP) through the hairless mouse skin showed a parabolic relationship with increased carbon length of the fatty acid enhancers. Among the fatty acids tested, oleic acid for DPB and palmitoleic acid for DPH showed the highest enhancing effect, respectively. Both the permeation rates of DPB and DPH evaluated in human cadaver skin were in good correlation with those in hairless mouse skin, regardless of the presence of fatty acids. This suggests that the mouse skin model serves as a useful in vitro system that satisfactorily represents the characteristics of the human skin. Moreover, based on the in vitro results, the optimal formulation that could maintain the human plasma concentration of 50 ng/mL was determined to be 10mg DP with 1% (w/v) enhancer. When the DP transdermal formulations were applied to the abdominal skin of rats (2.14 cm(2)), the C(ss) was maintained for 48 h, among which the highest value of 52.21 ± 2.09 ng/mL was achieved with the DPB formulation using oleic acid. These results showed that fatty acids could enhance the transdermal delivery of DP and suggested the feasibility of developing a novel transdermal delivery system for clinical use. Topics: Administration, Cutaneous; Animals; Cadaver; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Compounding; Fatty Acids, Monounsaturated; Humans; Indans; Male; Mice; Mice, Hairless; Oleic Acid; Permeability; Piperidines; Propylene Glycol; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption; Solubility; Solvents; Technology, Pharmaceutical | 2012 |
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients.
Obesity is a common problem following renal transplantation. Rimonabant, a cannabinoid-1 receptor blocker, offers a new approach for reducing obesity.. The potential pharmacokinetic interaction between rimonabant and cyclosporine A (CsA, n=10) and tacrolimus (Tac, n=8) was assessed in stable renal transplant recipients 6.2 (0.9-21.7) years posttransplant. A 12-hour pharmacokinetic profile was obtained before and after two months of concomitant treatment with 20 mg rimonabant each morning.. Rimonabant treatment induced a moderate, but significant increase in CsA AUC0-12 (19.8+/-16.1 %, P=0.005). Cmax and C2 values tended to increase whereas C0 remained unaffected. Tac pharmacokinetics was not significantly affected by rimonabant treatment. Eleven of 18 patients experienced adverse events. Two patients reported depressions and one reported severe nightmares.. The effect on CsA pharmacokinetics is probably of marginal clinical relevance since trough concentrations were unaltered, but CsA concentrations should probably be more closely monitored if rimonabant treatment is initiated, preferably by C2 monitoring. Topics: Adult; Anti-Obesity Agents; Area Under Curve; Cadaver; Cannabinoids; Cyclosporine; Drug Interactions; Female; Humans; Kidney Transplantation; Kinetics; Living Donors; Male; Middle Aged; Piperidines; Pyrazoles; Rimonabant; Tacrolimus; Tissue Donors | 2009 |
NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia.
Saturation analyses of [3H]L-689,560, [3H]CGP 39653 and NMDA-specific [3H]ifenprodil binding revealed an equivalent increase (0.7 pmol/mg) in the number of [3H]L-689,560 and [3H]ifenprodil binding sites in superior temporal cortex (BA22) from drug-treated chronic schizophrenic patients and control subjects. No differences were observed between control and schizophrenic subjects for [3H]CGP 39653 binding in BA22, or for any of the radioligands binding to pre-motor cortex (BA6). Since [3H]L-689,560, [3H]CGP 39653 and [3H]ifenprodil label the glycine, glutamate and ifenprodil sites of the NMDA receptor complex, which are associated with NR1, NR1/NR2A and NR1/NR2B subunits respectively, our findings suggest that NR2B-containing receptors are selectively up-regulated in superior temporal cortex in schizophrenia. Topics: 2-Amino-5-phosphonovalerate; Aminoquinolines; Binding Sites; Cadaver; Excitatory Amino Acid Antagonists; Humans; Isomerism; Piperidines; Receptors, N-Methyl-D-Aspartate; Reference Values; Schizophrenia; Temporal Lobe; Up-Regulation | 1999 |
[Loss of nicotine and anabasine during their isolation from biological material].
Topics: Cadaver; Ganglionic Blockers; Nicotine; Piperidines; Sulfuric Acids; Water | 1970 |
[Comparative evaluation of methods of isolation of nicotine and anabasine from biological material].
Topics: Cadaver; Ganglionic Blockers; Methods; Nicotine; Piperidines; Sulfuric Acids; Tissue Extracts | 1970 |
[THE TOXICOLOGICAL ANALYSIS OF TWO SUBSTANCES ORIGINATED BY PUTREFACTION].
Topics: Cadaver; Liver; Phenethylamines; Piperidines; Postmortem Changes; Toxicology | 1965 |